Zobrazeno 1 - 7
of 7
pro vyhledávání: '"MC Sánchez Argaiz"'
Autor:
MC Sánchez Argaiz, MJ Gándara Ladrón de Guevara, MI Sierra Torres, C Montero Vilchez, A Jimenez Morales
Publikováno v:
Section 5: Patient safety and quality assurance.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e038705f3bdab6851ac5388968da69c5
https://doi.org/10.1136/ejhpharm-2023-eahp.328
https://doi.org/10.1136/ejhpharm-2023-eahp.328
Publikováno v:
Section 4: Clinical pharmacy services.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1f4e061860bee73d9b82a64e9a7e98c2
https://doi.org/10.1136/ejhpharm-2022-eahp.71
https://doi.org/10.1136/ejhpharm-2022-eahp.71
Publikováno v:
Section 5: Patient safety and quality assurance.
Background and importance Treatment goals for advanced or metastatic breast cancer include not only delaying progression of the disease and extending survival, but also maintaining or improving the quality of the patient’s life. New targeted therap
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d45592c1a2b0551071f3ffcde8297815
https://doi.org/10.1136/ejhpharm-2021-eahpconf.285
https://doi.org/10.1136/ejhpharm-2021-eahpconf.285
Autor:
T Chinchilla Alarcón, B Mora Rodríguez, MC Sánchez Argaiz, M Ruiz De Villegas García-Pelayo, I Muñoz Castillo
Publikováno v:
Section 5: Patient Safety and Quality assurance.
Background and importance Treatment goals for advanced or metastatic breast cancer include not only delaying the progression of disease and extending survival, but also maintaining or improving quality of life for the patient. CDK4/6 inhibitors, such
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::604db5b434473927fa07502fef781701
https://doi.org/10.1136/ejhpharm-2020-eahpconf.364
https://doi.org/10.1136/ejhpharm-2020-eahpconf.364
Publikováno v:
Section 4: Clinical Pharmacy Services.
Background The current treatment for psoriasis depends on the severity of the disease, in mild disease topical therapies alone, and with increasing disease severity in combination with phototherapy and/or traditional systemic therapy (methotrexate, c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a1416f338bae89799148016f2eece03f
https://doi.org/10.1136/ejhpharm-2019-eahpconf.182
https://doi.org/10.1136/ejhpharm-2019-eahpconf.182
Publikováno v:
Section 5: Patient Safety and Quality Assurance.
Background Patients with multimorbidity are an especially complex population. Multimorbidity is associated with poorer health outcomes and significant polypharmacy. These make patients more vulnerable to drug-related problems, causing a higher number
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3f726dd18e2f449c485e255bececb41e
https://doi.org/10.1136/ejhpharm-2019-eahpconf.534
https://doi.org/10.1136/ejhpharm-2019-eahpconf.534
Autor:
MC Sánchez Argaiz, E Espínola García, MA Calleja Hernández, M Ferrit Martin, MC Pérez Pinilla
Publikováno v:
European Journal of Hospital Pharmacy. 23:A228.2-A229
Background One of the main causes of injuries and hospital admissions in older people is falls. The risk of falling can be increased by factors such as vision and balance problems, dementia and drug consumption. In 2012, pharmacists in primary care p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e4f4b2b2870b8b1b53a7e9ff071adc8f
https://doi.org/10.1136/ejhpharm-2016-000875.518
https://doi.org/10.1136/ejhpharm-2016-000875.518